How much funding has ChemT Biotechnology raised?

ChemT Biotechnology has raised $4.0M in total funding, most recently a Seed round.

Who are ChemT Biotechnology's investors?

ChemT Biotechnology's investors include Wavemaker Partners, Draper University.

When was ChemT Biotechnology founded?

ChemT Biotechnology was founded in 2024.

Where is ChemT Biotechnology headquartered?

ChemT Biotechnology is headquartered in Singapore, Singapore.

What industry is ChemT Biotechnology in?

ChemT Biotechnology operates in Artificial Intelligence, Biotech.

How many employees does ChemT Biotechnology have?

ChemT Biotechnology has 1-10 employees.

ChemT Biotechnology

Virtual Cell for Biomanufacturing

Singapore, Singapore · Founded 2024 · $4.0M raised

Artificial Intelligence

Biotech

Headquarters: Singapore
Employees: 1–10
Founded: 2024
Business Model: B2B

Website: chemtbio.com
Total Funding: $4.0M
Last Round: $4.0M SeedJun 2026
Rounds: 2

About

ChemT Biotechnology is an AI-driven biotech company based in Singapore and the United States, founded in October 2024 by CEO Jie Sun and President Dr. Ling Wu. The company is building the AI intelligence layer for CMC (Chemistry, Manufacturing & Controls) in pharma, with its proprietary CelMo virtual cell platform at the core — using AI-designed small molecules to modulate cells for improved growth, productivity, and product quality in biologics production. ChemT's technology targets faster process development, smoother validation, and lower-cost biologics manufacturing, with applications in cell therapy. The company is a member of Eli Lilly's TuneLab AI/ML innovation platform.

Summary

ChemT Biotechnology is an Artificial Intelligence company based in Singapore, Singapore, founded in 2024. It has raised $4.0M in total across 2 rounds, most recently a $4.0M Seed round in Jun 2026. Investors include Wavemaker Partners and Draper University.